Bain Capital
http://www.baincapital.comBain Capital, LLC is a global private investment firm that manages several pools of capital including private equity, venture capital, public equity and leveraged debt assets with more than $65 billion in assets under management. Since its inception in 1984, Bain Capital has made private equity investments and add-on acquisitions in more than 300 companies in a variety of industries around the world, and has a team of almost 300 professionals dedicated to investing in and supporting its portfolio companies, including such leading companies as Dunkin' Donuts, Michaels Stores and Domino's Pizza. Headquartered in Boston, Bain Capital has offices in New York, London, Munich, Hong Kong, Shanghai and Tokyo.
View Older Stories View More Recent Stories
-
CERE DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important June 3 Deadline in Securities Class Action - CERE
-
Pallet Secures $27M Series B Led by General Catalyst to Scale AI Workforce for Logistics
-
CERE DEADLINE ALERT: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline i
-
CERE DEADLINE ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Sec
-
CERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE
-
Form 8-K Bain Capital Specialty For: May 22
-
Form 8-K Bain Capital Private For: May 19
-
Subscription management platform RevenueCat raises $50 million in Series C funding
-
RevenueCat Raises $50M Series C to Expand Global Infrastructure for Consumer Software Monetization
-
ROSEN, A LEADING LAW FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE
-
Money20/20 Unveils Global Powerhouse Jury for Inaugural Money Awards
-
Money20/20 Unveils Global Powerhouse Jury for Inaugural Money Awards
-
Finley Unveils Software-Powered Monthly Servicer Reporting to Streamline Asset-Based Lending Transactions
-
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE
-
Form 4 Waystar Holding Corp. For: May 16 Filed by: BAIN CAPITAL INVESTORS LLC
-
Acrisure Secures $2.1 Billion Funding Round Led by Bain Capital
-
Financial services firm Acrisure valued at $32 billion in Bain-led funding round
-
HCAP Partners Announces Successful Exit from Arosa
-
Argyle launches new integration, bringing real-time income and employment verification to Byte LOS customers
-
Form APP NTC Lincoln Bain Capital
-
Aware, Inc. (AWRE) appoints Lona Therrien as CMO
-
Aware Taps Proven Cybersecurity Leader Lona Therrien to Boost Brand as Chief Marketing Officer
-
The Mutual Group Appoints Peter Houston as Chief Growth Officer and Head of Corporate Development
-
Proptech Innovator Roofstock Launches Short-Term Rental Management Division With Investment in Casago
-
CERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
ROSEN, A LEADING LAW FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE
-
ROSEN, A LEADING LAW FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE
-
Nutanix Announces Updates to its Board of Directors
-
Form D/A DCM Bain Capital Private
-
Form 10-Q Bain Capital Private For: Mar 31
-
Pronto Raises $2M to Reimagine India’s Domestic Labor Market with On-Demand Services and Income Stability for Workers
-
EvenUp Launches AI Drafts Suite, Smart Workflows, Medical Bill Summary, and Case-Based Pricing to Redefine Legal Automation for Personal Injury Firms
-
Cofactr Acquires Custom Hardware Sourcing Solution Cogbase to Scale Manufacturers’ Supplier Networks in the U.S.
-
Scream Truck Partners with Ansa to Enhance Payments Experience
-
Form 13F-NT Bain Capital Partners For: Mar 31
-
Form 13F-NT Bain Capital Venture For: Mar 31
-
Form 13F-NT Bain Capital Venture For: Mar 31
-
Form 13F-NT Bain Capital Life Scienc For: Mar 31
-
Form SCHEDULE 13G/A Olema Pharmaceuticals, Filed by: Bain Capital Life Sciences Opportunities IV, L.P.
-
Form 13F-NT Bain Capital Life Scienc For: Mar 31
-
Form 13F-HR BAIN CAPITAL VENTURE For: Mar 31
-
Form 13F-NT Bain Capital Life Scienc For: Mar 31
-
Form 13F-NT Bain Capital Fund XII, For: Mar 31
-
Form 13F-NT Bain Capital Fund XI, For: Mar 31
-
Form 13F-NT Bain Capital Venture For: Mar 31
-
Form 13F-NT Bain Capital Life Scienc For: Mar 31
-
Form 13F-NT Bain Capital Life Scienc For: Mar 31
-
Form 13F-NT Bain Capital Life Scienc For: Mar 31
